Stocks and Investing Stocks and Investing
Fri, January 21, 2022

Geoff Meacham Upgraded (ABOS) to Strong Buy and Decreased Target to $14 on, Jan 21st, 2022


Published on 2024-10-27 19:22:43 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Upgraded "Acumen Pharmaceuticals, Inc." (ABOS) to Strong Buy and Decreased Target from $16 to $14 on, Jan 21st, 2022.

Geoff, nor any peers, have made any analyst calls on ABOS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources